Hogil v. Care Technologies lice treatment claims suit could get hearing by year-end.
This article was originally published in The Tan Sheet
Executive Summary
HOGIL COURT CHALLENGE OF CARE TECHNOLOGIES' CLEAR LICE TREATMENT AD CLAIMS could be the subject of a hearing in Manhattan federal court before the end of the year. Purchase, N.Y.-based Hogil Pharmaceuticals contests a number of claims made by Care Technologies about its line of OTC pediculicide products in a complaint and demand for jury trial filed March 4. Care Technologies subsequently submitted an answer to the complaint April 25. The case is in discovery.